SCHEMBL5717002

SCHEMBL5717002

CCOC(=O)C1CCCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 3/20 0.62
HCRTR2 O43614 3/20 0.62
ALDH1A1 P00352 6/20 0.58
KDM4E B2RXH2 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.54
FKBP1A P62942 3/20 0.50
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
TSHR P16473 4/20 0.44
MAPK1 P28482 1/20 0.44
RECQL P46063 1/20 0.44
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTT P42858 1/20 0.42
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717089 0.91 ALDH1A1 (0.58) HCRTR1HCRTR2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL5717267 0.88 ALDH1A1 (0.55) HCRTR1HCRTR2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL5717094 0.88 HCRTR1 (0.61) HCRTR1HCRTR2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL5717121 0.88 ALDH1A1 (0.56) HCRTR1HCRTR2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL5717057 0.85 HCRTR1 (0.60) HCRTR1HCRTR2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL5717024 0.84 HCRTR1 (0.64) HCRTR1HCRTR2ALDH1A1MEN1KMT2A
SCHEMBL5717026 0.84 FKBP1A (0.50) HCRTR1HCRTR2ALDH1A1KDM4EFKBP1A
SCHEMBL5717227 0.83 ALDH1A1 (0.64) HCRTR1HCRTR2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL5717102 0.83 ALDH1A1 (0.64) HCRTR1HCRTR2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL5717100 0.83 ALDH1A1 (0.64) HCRTR1HCRTR2ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP disclosed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO disclosed